Virbac : L’inflexion attendue est désormais perçue comme durablement engagée
>Redressement « self helped » - Sur la base de résultats faisant ressortir une baisse de 34 M€ de la dette nette et une hausse de la MOP d’environ 80 pb à 10% des ventes, nous avons organisé un roadshow à Londres. Il ressort que :La situation aux USA se stabilise (moindre effet destockage) pour les anti-parasitaires Iverheart® et Sentinel®, mais le reste des gammes (50% du CA local) progresse de plus de 20% (regain de PdM). La marge contributive de la filiale dev...Virbac is an independent veterinary pharmaceutical laboratory. Co. develops and provides veterinarians and farmers with medicines and vaccines that improve the health of food producing animals. Co. markets a range of products designed for pets and livestock. It offers seven types of products for companion animals (Parasiticides, Immunology, Antibiotics/dermatology, Specialties, Equine, Specialized pet food and Other products), and four types of products for food producing animals (Bovine parasiticides, Bovine products (excluding parasiticides), Pig/poultry antibiotics and Other products). Co. markets its products in the ethical (veterinarian) and OTC markets.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.